- Home
- SGBX vs GLMD Comparison
SGBX vs GLMD Comparison
Compare SGBX & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGBX
- GLMD
- Stock Information
- Founded
- SGBX 2007
- GLMD 2000
- Country
- SGBX United States
- GLMD Israel
- Employees
- SGBX N/A
- GLMD N/A
- Industry
- SGBX RETAIL: Building Materials
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- SGBX Consumer Discretionary
- GLMD Health Care
- Exchange
- SGBX Nasdaq
- GLMD Nasdaq
- Market Cap
- SGBX 2.7M
- GLMD 3.0M
- IPO Year
- SGBX 2017
- GLMD 2014
- Fundamental
- Price
- SGBX $0.81
- GLMD $1.51
- Analyst Decision
- SGBX
- GLMD Hold
- Analyst Count
- SGBX 0
- GLMD 1
- Target Price
- SGBX N/A
- GLMD N/A
- AVG Volume (30 Days)
- SGBX 11.2M
- GLMD 255.6K
- Earning Date
- SGBX 06-17-2025
- GLMD 06-17-2025
- Dividend Yield
- SGBX N/A
- GLMD N/A
- EPS Growth
- SGBX N/A
- GLMD N/A
- EPS
- SGBX N/A
- GLMD N/A
- Revenue
- SGBX $4,976,618.00
- GLMD N/A
- Revenue This Year
- SGBX $1,628.82
- GLMD N/A
- Revenue Next Year
- SGBX N/A
- GLMD N/A
- P/E Ratio
- SGBX N/A
- GLMD N/A
- Revenue Growth
- SGBX N/A
- GLMD N/A
- 52 Week Low
- SGBX $0.30
- GLMD $1.15
- 52 Week High
- SGBX $3.75
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- SGBX 51.99
- GLMD 56.28
- Support Level
- SGBX $0.40
- GLMD $1.36
- Resistance Level
- SGBX $1.50
- GLMD $1.60
- Average True Range (ATR)
- SGBX 0.23
- GLMD 0.09
- MACD
- SGBX 0.02
- GLMD 0.03
- Stochastic Oscillator
- SGBX 37.04
- GLMD 79.07
About SGBX Safe & Green Holdings Corp.
Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.